Decode Shares Slide 8 Percent After Firm Said It Would Raise $30M in Stock Placement | GenomeWeb
NEW YORK (GenomeWeb News) - Shares in Decode Genetics were down 8.1 percent, or $.46, at $5.22 in mid-afternoon trading after the company said it plans to  raise $30 million in a private stock placement.
 
As GenomeWeb News reported this morning, the Icelandic company said it plans to sell 6 million shares at $5 apiece to existing and new institutional investors.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.